Humoral Immunity and Adverse Events after Vaccination Against COVID-19 By a Vector Based Vaccine Sputnik V in Patients with Chronic Myeloid Leukemia

Introduction Data on the effectiveness and safety of new vaccines against COVID-19 in patients (pts) with hematological diseases are just beginning to accumulate. We planned to obtain such information for pts with chronic myeloid leukemia (CML) during vaccination. Objective. To evaluate the antibodi...

Descripción completa

Detalles Bibliográficos
Autores principales: Chelysheva, Ekaterina Yu., Petrova, Anna, Shukhov, Oleg A., Gurianova, Margarita, Bykova, Anastasiya, Nemchenko, Irina, Tsyba, Nikolay, Tikhomirov, Dmitry S., Turkina, Anna G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Hematology. Published by Elsevier Inc. 2021
Materias:
632.Chronic Myeloid Leukemia: Clinical and Epidemiological
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8701496/
http://dx.doi.org/10.1182/blood-2021-152701

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8701496/
http://dx.doi.org/10.1182/blood-2021-152701

Ejemplares similares